| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 237.569 | 85 |
| GSM780708 | Untreated after 4 days (C2_1) | 207.826 | 84 |
| GSM780709 | Untreated after 4 days (C3_1) | 219.439 | 84 |
| GSM780719 | Untreated after 4 days (C1_2) | 219.894 | 85 |
| GSM780720 | Untreated after 4 days (C2_2) | 226.694 | 85 |
| GSM780721 | Untreated after 4 days (C3_2) | 231.771 | 85 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 258.667 | 86 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 205.038 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 224.646 | 85 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 222.919 | 85 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 230.764 | 85 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 217.692 | 84 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 221.749 | 85 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 234.004 | 85 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 203.983 | 84 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 217.415 | 84 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 239.696 | 85 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 220.691 | 85 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 247.221 | 86 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 235.824 | 85 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 198.516 | 83 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 199.447 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 222.698 | 85 |